Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Palisade Bio, Inc. (PALI) had Normalized Pre-Tax Income of $-9.60M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-9.60M |
|
-- |
|
-- |
|
$10.75M |
|
$-10.75M |
|
$1.15M |
|
$-9.60M |
|
|
Normalized Pre-Tax Income |
$-9.60M |
$-9.60M |
|
$-9.60M |
|
$-9.60M |
|
$-9.60M |
|
$-10.75M |
|
$-10.75M |
|
209.66M |
|
209.66M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$133.24M |
|
-- |
|
$0.07M |
|
$133.31M |
|
$5.62M |
|
-- |
|
$0.33M |
|
$5.95M |
|
$127.36M |
|
$127.36M |
|
$127.36M |
|
167.42M |
|
| Cash Flow Statement Financials | |
$-3.89M |
|
-- |
|
$3.13M |
|
$133.44M |
|
$132.68M |
|
$-0.76M |
|
$4.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.54% |
|
-7.54% |
|
-7.20% |
|
-7.54% |
|
$0.76 |
|
$-0.02 |
|
$-0.02 |
|